The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
89bio
ETNB
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$9.24
-0.42
-4.35%
At Close: -
$9.24
0
0.00%
After Hours: Jul 26, 4:00 PM EDT
15 minutes delayed
Get Report
Comment
89bio (ETNB) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for 89bio (NASDAQ:ETNB) Stock
89bio Stock (NASDAQ: ETNB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 01, 2024
Cantor Fitzgerald Reiterates Overweight on 89...
Benzinga Newsdesk
Monday, June 17, 2024
Cantor Fitzgerald Reiterates Overweight on 89...
Benzinga Newsdesk
Wednesday, June 12, 2024
Cantor Fitzgerald Reiterates Overweight on 89...
Benzinga Newsdesk
Tuesday, June 11, 2024
HC Wainwright & Co. Reiterates Buy on 89bio, ...
Benzinga Newsdesk
Wednesday, June 05, 2024
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
Vandana Singh
Wednesday, May 22, 2024
89bio Will Present 48-Week Data From ENLIVEN ...
Benzinga Newsdesk
Friday, May 17, 2024
Cantor Fitzgerald Reiterates Overweight on 89...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on 89bio, ...
Benzinga Newsdesk
Thursday, May 16, 2024
HC Wainwright & Co. Reiterates Buy on 89bio, ...
Benzinga Newsdesk
Wednesday, May 15, 2024
Evercore ISI Group Maintains Outperform on 89...
Benzinga Newsdesk
Tuesday, May 14, 2024
89bio Initiates Phase 3 ENLIGHTEN-Cirrhosis T...
Benzinga Newsdesk
Friday, May 10, 2024
HC Wainwright & Co. Maintains Buy on 89bio, L...
Benzinga Newsdesk
Thursday, May 09, 2024
89bio Q1 2024 GAAP EPS $(0.54) Misses $(0.46)...
Benzinga Newsdesk
Monday, April 22, 2024
B of A Securities Assumes 89bio at Buy, Annou...
Benzinga Newsdesk
Wednesday, April 10, 2024
On April 4, 2024, 89Bio Entered Into Collabor...
Benzinga Newsdesk
Friday, April 05, 2024
Cantor Fitzgerald Reiterates Overweight on 89...
Benzinga Newsdesk
Wednesday, March 27, 2024
HC Wainwright & Co. Maintains Buy on 89bio, M...
Benzinga Newsdesk
89bio Receives EMA PRIME Status For Pegozafer...
Benzinga Newsdesk
Wednesday, March 13, 2024
HC Wainwright & Co. Maintains Buy on 89bio, M...
Benzinga Newsdesk
Tuesday, March 12, 2024
89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Tr...
Benzinga Newsdesk
Thursday, March 07, 2024
Evercore ISI Group Maintains Outperform on 89...
Benzinga Newsdesk
Over $20M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Avi Kapoor
Wednesday, March 06, 2024
Evercore ISI Group Maintains Outperform on 89...
Benzinga Newsdesk
Tuesday, March 05, 2024
Oppenheimer Maintains Perform on 89bioto Perf...
Benzinga Newsdesk
Monday, March 04, 2024
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Cantor Fitzgerald Reiterates Overweight on 89...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Friday, March 01, 2024
RBC Capital Maintains Sector Perform on 89bio...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on 89bio, L...
Benzinga Newsdesk
Thursday, February 29, 2024
89bio Q4 EPS $(0.50) Misses $(0.49) Estimate
Happy Mohamed
Friday, January 12, 2024
Liver Disease Player 89Bio Downgraded: Analyst Sees Short-Term Uncertainties In Fatty Liver Drug Development
Vandana Singh
RBC Capital Downgrades 89bio to Sector Perfor...
Benzinga Newsdesk
Wednesday, December 20, 2023
HC Wainwright & Co. Maintains Buy on 89bio, L...
Benzinga Newsdesk
Thursday, December 07, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
89bio Announces Pricing Of Previously Announc...
Benzinga Newsdesk
Sprinklr Reports Downbeat Earnings, Joins Chewy, GameStop And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Wednesday, December 06, 2023
89bio Plans Public Offering Of Common Stock A...
Benzinga Newsdesk
Tuesday, December 05, 2023
HC Wainwright & Co. Reiterates Buy on 89bio, ...
Benzinga Newsdesk
Monday, December 04, 2023
89bio Outlines Roadmap For Pivotal Studies For Lead Program In Fatty Liver Disease
Vandana Singh
89bio Reaches Alignment with the FDA And EMA ...
Benzinga Newsdesk
Tuesday, November 28, 2023
Analyst Ratings for 89bio
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on 89bio, ...
Benzinga Newsdesk
Monday, November 27, 2023
89bio's Fatty Liver Candidate Shows Long-Term Improvement: Details
Vandana Singh
89Bio Announced Topline Data From The Blinded...
Benzinga Newsdesk
Sunday, November 12, 2023
89bio Announces Additional Data From The ENLI...
Benzinga Newsdesk
Thursday, November 09, 2023
RBC Capital Maintains Outperform on 89bio, Lo...
Benzinga Newsdesk
Wednesday, November 08, 2023
89bio Q3 EPS $(0.45) Beats $(0.53) Estimate
Benzinga Newsdesk
Thursday, October 12, 2023
UBS Maintains Buy on 89bio, Lowers Price Targ...
Benzinga Newsdesk
Wednesday, October 11, 2023
Analyst Expectations for 89bio's Future
Benzinga Insights
89bio shares are trading lower after RBC Capi...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
